Diseases of the Pancreas, II: Tumors

  • Ruedi F. Thoeni


In the imaging of pancreatic disease and in assessment of the etiology of jaundice, abdominal ultrasound (US) and computed tomography (CT) traditionally have been employed [1]. These two methods are widely available and have the advantages of their familiarity to radiologists and clinicians and their non-invasiveness. With the introduction of magnetic resonance imaging (MRI), magnetic resonance cholangiopancreatography (MRCP), and endoscopic ultrasound (EUS), visualization of the pancreatic and biliary ducts improved, allowing tumors to be more accurately staged and safely sampled [2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12]. This led to a diminishing role for endoscopic retrograde cholangiography in the diagnostic arena but its therapeutic use has remained unchallenged. In recent years, technological advances with multidetector row CT (MDCT) imaging have improved the ability of CT to detect even small lesions in the pancreas and to stage pancreatic tumors more accurately [13]. Microbubble contrast enhancement and secretin stimulation have increased the diagnostic acumen of US and MRI, respectively, and may widen the utility of these techniques [14, 15].


Pancreatic Cancer Pancreatic Duct Cystic Neoplasm Intraductal Papillary Mucinous Neoplasm Islet Cell Tumor 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bipat S, Phoa SS, van Delden OM et al (2005) Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis and determining resectability of pancreatic adenocarcinoma: a meta-analysis. J Comput Assist Tomogr 29: 438–445CrossRefPubMedGoogle Scholar
  2. 2.
    Midwinter MJ, Beveridge CJ, Wilsdon JB et al (1999) Correlation between spiral computed tomography, endoscopic ultrasonography and findings at operation in pancreatic and ampullary tumours. British J Surg 86:189–193CrossRefGoogle Scholar
  3. 3.
    McLean AM, Fairclough PD (2005) Endoscopic ultrasound in the localisation of pancreatic islet cell tumours. Best Pract Res Clin Endocrinol Metab 19:177–193CrossRefPubMedGoogle Scholar
  4. 4.
    Canto MI, Goggins M, Yeo CJ et al (2004) Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach. Clin Gastroenterol Hepatol 2:606–621CrossRefPubMedGoogle Scholar
  5. 5.
    Thoeni RF, Mueller-Lisse UG, Chan R et al (2000) Detection of small, functional islet cell tumors in the pancreas: Selection of MRI Imaging sequences for optimal sensitivity. Radiology 214:483–490PubMedGoogle Scholar
  6. 6.
    Semelka RC, Kroeker MA, Shoenut JP et al (1991) Pancreatic disease: prospective comparison of CT, ERCP, and 1.5 T MR imaging with dynamic Gadolinium enhancement and fat suppression. Radiology 181:785–791PubMedGoogle Scholar
  7. 7.
    Volmar KE, Vollmer RT, Jowell PS et al (2005) Pancreatic FNA in 1000 cases: a comparison of imaging modalities. Gastrointest Endosc 61:854–861CrossRefPubMedGoogle Scholar
  8. 8.
    Ardengh JC, de Paulo GA, Ferrari AP (2004) EUS-guided FNA in the diagnosis of pancreatic neuroendocrine tumors before surgery. Gastrointest Endosc 60:378–384CrossRefPubMedGoogle Scholar
  9. 9.
    Maguchi H (2004) The roles of endoscopic ultrasonography in the diagnosis of pancreatic tumors. J Hepatobiliary Pancreat Surg 11:1–3CrossRefPubMedGoogle Scholar
  10. 10.
    Vachiranubhap B, Kim YH, Balci NC et al (2009) Magnetic resonance imaging of adenocarcinoma of the pancreas. Top Magn Reson Imaging 20:3–9CrossRefPubMedGoogle Scholar
  11. 11.
    Manfredi R, Graziani R, Motton M et al (2009) Main pancreatic duct intraductal papillary mucinous neoplasms: accuracy of MR imaging in differentiation between benign and malignant tumors compared with histopathologic analysis. Radiology 253:106–115CrossRefPubMedGoogle Scholar
  12. 12.
    Ku YM, Shin SS, Lee CH et al (2009) Magnetic resonance imaging of cystic and endocrine pancreatic neoplasms. Top Magn Reson Imaging 20:11–18CrossRefPubMedGoogle Scholar
  13. 13.
    Brennan DD, Zamboni GA, Raptopoulos VD et al (2007) Comprehensive preoperative assessment of pancreatic adenocarcinoma with 64-section volumetric CT. Radiographics 27:1653–1666.CrossRefPubMedGoogle Scholar
  14. 14.
    D’Onofrio M, Zamboni G, Faccioli N et al (2007) Ultrasono-graphy of the pancreas. 4. Contrast-enhanced imaging. Abdom Imaging 32:171–181CrossRefPubMedGoogle Scholar
  15. 15.
    Akisik MF, Sandrasegaran K, Aisen AA et al (2006) Dynamic secretin-enhanced MR cholangiopancreatography. Radio-graphics 26:665–677Google Scholar
  16. 16.
    Lytras D, Connor S, Bosonnet L et al (2005) Positron emission tomography does not add to computed tomography for the diagnosis and staging of pancreatic cancer. Dig Surg 22:55–61CrossRefPubMedGoogle Scholar
  17. 17.
    Heinrich S, Goerres GW, Schafer M et al (2005) Positron emission tomography/computed tomography influences on the management of resectable pancreatic cancer and its cost-effectiveness. Ann Surg 242:235–243CrossRefPubMedGoogle Scholar
  18. 18.
    Ruf J, Lopez Hanninen E, Oettle H et al (2005) Detection of recurrent pancreatic cancer: comparison of FDG-PET with CT/MRI. Pancreatology 5:266–272CrossRefPubMedGoogle Scholar
  19. 19.
    Orlando LA, Kulasingam SL, Matchar DB (2004) Meta-analysis: the detection of pancreatic malignancy with positron emission tomography. Aliment Pharmacol Ther 20:1063–1070CrossRefPubMedGoogle Scholar
  20. 20.
    Lee TY, Kim MH, Park do H et al (2009) Utility of 18F-FDG PET/CT for differentiation of autoimmune pancreatitis with atypical pancreatic imaging findings from pancreatic cancer. AJR Am J Roentgenol 193:343–348CrossRefPubMedGoogle Scholar
  21. 21.
    Farma JM, Santillan AA, Melis M et al (2008) PET/CT fusion scan enhances CT staging in patients with pancreatic neoplasms. Ann Surg Oncol 15:2465–2471CrossRefPubMedGoogle Scholar
  22. 22.
    Virgolini I, Traub-Weidinger T, Decristoforo C (2005) Nuclear medicine in the detection and management of pancreatic isletcell tumours. Best Pract Res Clin Endocrinol Metab 19:213–227CrossRefPubMedGoogle Scholar
  23. 23.
    Buchmann I, Henze M, Engelbrecht S et al (2007) Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours. Eur J Nucl Med Mol Imaging 34:1617–1726CrossRefPubMedGoogle Scholar
  24. 24.
    Horner MJ, Ries LAG, Krapcho M et al (eds) posted to the SEER web site (2009) SEER Cancer Statistics Review, 1975–2006, National Cancer Institute. Bethesda, MD, based on November 2008 SEER data submission, http://seer.cancer.gov/csr/1975_2006Google Scholar
  25. 25.
    Cancer Facts & Figures (2009) American Cancer Society (ACS), Atlanta, GeorgiaGoogle Scholar
  26. 26.
    Fletcher JG, Wiersema MJ, Farrell MA et al (2003) Pancreatic malignancy: value of arterial, pancreatic, and hepatic phase imaging with multi-detector row CT. Radiology 229:81–90CrossRefPubMedGoogle Scholar
  27. 27.
    Imbriaco M, Megibow AJ, Ragozzino A et al (2005) Value of the single-phase technique in MDCT assessment of pancreatic tumors. AJR Am J Roentgenol 184:1111–1117PubMedGoogle Scholar
  28. 28.
    Sahani DV, Kadavigere R, Saokar A et al (2005) Cystic pancreatic lesions: a simple imaging-based classification system for guiding management. Radiographics 25:1471–1484CrossRefPubMedGoogle Scholar
  29. 29.
    Morris-Stiff G, Webster P, Frost B et al (2009) Endoscopic ultrasound reliably identifies chronic pancreatitis when other imaging modalities have been non-diagnostic. JOP 10: 280–283PubMedGoogle Scholar
  30. 30.
    Aslanian H, Salem R, Lee J et al (2005) EUS diagnosis of vascular invasion in pancreatic cancer: surgical and histologic correlates. Am J Gastroenterol 100:1381–1385CrossRefPubMedGoogle Scholar
  31. 31.
    Thoeni RF (2009) Imaging of endocrine tumors. In: Heiken JP (ed) Pancreatic cancer. Contemporary issues in cancer imaging. Cambridge University Press, Cambridge, pp 104–129Google Scholar
  32. 32.
    Gouya H, Vignaux O, Augui J et al (2003) CT, EUS combined protocol for preoperative evaluation of pancreatic insulinoma. AJR Am J Roentgenol 181:987–992PubMedGoogle Scholar
  33. 33.
    T. Zimmer, U. Stolzel, M. Bader et al (1996) Endoscopic ultrasonography and somatostatin receptor scintigraphy in the preoperative localisation of insulinomas and gastrinomas. Gut 39:562–568CrossRefPubMedGoogle Scholar
  34. 34.
    Pisegna JR, Doppman JL, Norton JA et al (1993) Prospective comparative study of the ability of MR imaging and other imaging modalities to localize tumors in patients with Zollinger-Ellison syndrome. Dig Dis Sci 38:1318–1320CrossRefPubMedGoogle Scholar
  35. 35.
    H. Liang H, Wang P, Wang XN et al (2004) Management of nonfunctioning islet cell tumors. World J Gastroenterol 10:1806–1809PubMedGoogle Scholar
  36. 36.
    Spinelli KS, Fromwiller TE, Daniel RA et al (2004) Cystic pancreatic neoplasms: Observe or operate. Ann Surg 239:651–659CrossRefPubMedGoogle Scholar
  37. 37.
    Procacci C, Graziani R, Bicego E et al (1997) Serous cystadenoma of the pancreas: report of 30 cases with emphasis on the imaging findings. J Comput Assist Tomogr 21:373–382CrossRefPubMedGoogle Scholar
  38. 38.
    Belsley NA, Pitman MB, Lauwers GY et al (2008) Serous cystadenoma of the pancreas: limitations and pitfalls of endoscopic ultrasound-guided fine-needle aspiration biopsy. Cancer 114:102–110CrossRefPubMedGoogle Scholar
  39. 39.
    Ogawa H, Itoh S, Ikeda M et al (2008) Intraductal papillary mucinous neoplasm of the pancreas: assessment of the likelihood of invasiveness with multisection CT. Radiology 248:876–886CrossRefPubMedGoogle Scholar
  40. 40.
    Lee JH, Yu JS, Kim H et al (2008) Solid pseudopapillary carcinoma of the pancreas: differentiation from benign solid pseudopapillary tumour using CT and MRI. Clin Radiol 63:1006–1014CrossRefPubMedGoogle Scholar

Copyright information

© Springer Verlag Italia 2010

Authors and Affiliations

  • Ruedi F. Thoeni
    • 1
  1. 1.Department of Radiology and Biomedical ImagingUniversity of CaliforniaSan FranciscoUSA

Personalised recommendations